Retour à la liste

Group Chief Medical Officer

International Permanent CA$614,447 - CA$750,991 par an Voir la description de poste
This Global Chief Medical Officer, the most senior medical leader for the company, setting the overall clinical and medical strategy across the group.

Ce poste utilise des outils assistés par l’IA afin de soutenir la présélection initiale. Toutes les évaluations et décisions sont prises par un examinateur humain.

  • Group Chief Medical Officer cross mutiple therapeutic area globally.
  • AI driven antibody drug development platform

À propos de notre client

This is a listed, AI driven antibody drug development platform, cross muitlple therapeutic areas. This biopharma company provides operation sites in USA, China and Europe.

Description de poste

Key Responsibilities:

  • Set group-wide clinical development strategy across the four TAs (Oncology, Immunology, Obesity/Metabolic, Neuroscience), including prioritization and go/no-go.
  • Provide clinical/medical governance and standards across HM and NewCos; coordinate resources and avoid duplication.
  • Oversee global registration strategy, China (NMPA) + US (FDA) dual filing and multi-regional trials.
  • Support group BD (shift to in-licensing): medical due diligence and value judgment on assets.
  • Partner with RA (regulatory), KOLs and health authorities; represent HBM's medical voice externally.
  • Build and develop clinical/medical leadership and matrix teams across entities.



MPI does not discriminate on the basis of race, religion, sex, sexual orientation, gender identity or expression, age, disability, marital status, or based on an individual's status in any group or class otherwise protected under applicable human rights legislation. MPI encourages applications from minorities, women, the disabled and all other qualified applicants

Le candidat idéal

Key Requirements:

  • PhD, MD, Mutinational Corporate and biotech blended background, brings big-pharma global rigor and biotech agility to the team
  • Strong reputation and stability; China / US / cross-border experience; base both in China and USA
  • Broad, cross-therapeutic area clinical development expertise (Ph1-Ph3, IND/BLA/NDA); comfortable across multiple therapeutic areas, not a single-TA specialist.
  • Experience with complex biologics/large molecules (antibodies, bispecifics/multispecifics, TCE, ADC), aligned with HBM's core modalities.
  • Global registration experience, China + US dual filing, multi-regional / MNC collaboration (e.g., AZ, BMS).
  • Group / multi-product / multi-TA CMO or senior clinical leadership experience (not single-product CMO).
  • Strategic and matrix leadership, ability to steer and align franchises with gravitas; cross-functional (R&D/RA/BD/CMC/Commercial).

MPI does not discriminate on the basis of race, religion, sex, sexual orientation, gender identity or expression, age, disability, marital status, or based on an individual's status in any group or class otherwise protected under applicable human rights legislation. MPI encourages applications from minorities, women, the disabled and all other qualified applicants.

Ce qui est offert

  • Competitive annual salary ranging from $450000 to $550000 USD.
  • Permanent position within the life sciences industry.
  • Location in Shanghai offering a varied and diverse environment.
  • Additional benefits to be discussed during the hiring process.



If this role aligns with your experience, we encourage you to apply.

Contact
Annie Shen
Indiquer la référence de l'offre
JN-092026-7094751

Résumé du poste

Secteur d’activité
Ingénierie et Production
Sous-secteur
Direction Générale
Industrie
Healthcare / Pharmaceutical
Où
International
Type de poste
Permanent
Nom du consultant
Annie Shen
Numéro de référence d’emploi
JN-092026-7094751